CareLit · DOI-Nachweis · Aktuelle Neurologie
Anti-myelin antibodies and the risk of relapse in patients with a primary demyelinating event
DOI 10.1055/s-2005-919602
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Rauer, B Euler, T Berger, M Reindl
ZeitschriftAktuelle Neurologie
Ausgabe10/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
According to Berger et al. the presence of antimyelin antibodies may predict a clinically definite multiple sclerosis after a first demyelinating event (NEJM 349, 2003). Sera from 45 patients with a clinically isolated syndrome (CIS) and positive oligoclonal bands in cerebrospinal fluid (CSF) were retrospectively tested for the presence of IgM antibodies against both myelin oligodendrocyte glycoprotein (MOG) and mye…
Zitieren
Zitierempfehlung
S Rauer, B Euler, T Berger, M Reindl (2005) Anti-myelin antibodies and the risk of relapse in patients with a primary demyelinating event. Aktuelle Neurologie (10). https://doi.org/10.1055/s-2005-919602
Mit CareLit weiterarbeiten